Ligand Pharmaceuticals
LGND
LGND
195 hedge funds and large institutions have $946M invested in Ligand Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 66 increasing their positions, 77 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
14% less repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 77
16% less capital invested
Capital invested by funds: $1.12B → $946M (-$177M)
26% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 27
Holders
195
Holding in Top 10
1
Calls
$5.38M
Puts
$2.38M
Top Buyers
| 1 | +$9.27M | |
| 2 | +$4.97M | |
| 3 | +$4.07M | |
| 4 |
D.E. Shaw & Co
New York
|
+$3.26M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$2.45M |
Top Sellers
| 1 | -$10.5M | |
| 2 | -$4.11M | |
| 3 | -$3.9M | |
| 4 |
CC
Chicago Capital
Chicago,
Illinois
|
-$3.82M |
| 5 |
BC
Burney Company
Reston,
Virginia
|
-$3.75M |